FindTrial
Sign In

Modified Child-Pugh versus Albumin-Bilirubin grading system for prognosis in hepatocellular carcinoma patients after hepatectomy

Modified Child-Pugh versus Albumin-Bilirubin grading system for prognosis in hepatocellular carcinoma patients after hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026738
Enrollment
Unknown
Registered
2019-10-20
Start date
2019-10-20
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Gold Standard:Clinical outcome
Index test:modified&#32
child-pugh&#32
(MCP)&#32
grading&#32
system
&#32
albumin-bilirubin(ALBI)&#32

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1) Pathological identified as HCC; (2) Adequate clinical data could be checked in the hospital.

Exclusion criteria

Exclusion criteria: Had been treated prior to hepatic resection, such as radio frequency Xiao Rongguang, TACE and so on; complicated with other malignancies;

Design outcomes

Primary

MeasureTime frame
Overall survival time;recurrence free time;—

Countries

China

Contacts

Public ContactFeng Huang

The Second Affiliated Hospital of Chongqing Medical University

764102201@qq.com+86 13667626706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026